(+)-pilocarpine increases expression EXP 6480464 Pilocarpine results in increased expression of CDKN1B mRNA CTD PMID:17971868 (+)-Tetrandrine increases expression ISO RGD:69115 6480464 tetrandrine results in increased expression of CDKN1B protein CTD PMID:30123091 (+)-Tetrandrine multiple interactions ISO RGD:69115 6480464 [sodium arsenite co-treated with tetrandrine] results in increased expression of CDKN1B protein CTD PMID:30123091 (-)-citrinin decreases expression ISO RGD:69115 6480464 Citrinin results in decreased expression of CDKN1B mRNA CTD PMID:30428381 (-)-citrinin multiple interactions ISO RGD:69115 6480464 [Citrinin co-treated with ochratoxin A] results in decreased expression of CDKN1B mRNA, [Citrinin co-treated with ochratoxin A] results in increased expression of CDKN1B mRNA CTD PMID:30428381 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:69115 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDKN1B mRNA CTD PMID:22079256 (S)-(-)-perillyl alcohol increases expression ISO RGD:69115 6480464 perillyl alcohol results in increased expression of CDKN1B protein CTD PMID:17138864 (S)-(-)-perillyl alcohol increases response to substance ISO RGD:69115 6480464 CDKN1B protein results in increased susceptibility to perillyl alcohol CTD PMID:17138864 (S)-(-)-perillyl alcohol multiple interactions ISO RGD:69115 6480464 perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] CTD PMID:17138864 (S)-nicotine multiple interactions ISO RGD:69115 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Nicotine results in decreased expression of CDKN1B protein], Nicotine results in increased expression of and results in increased stability of CDKN1B protein CTD PMID:15231866 , PMID:18805435 (S)-nicotine decreases expression ISO RGD:69115 6480464 Nicotine results in decreased expression of CDKN1B protein CTD PMID:18805435 (Z)-3-butylidenephthalide increases expression EXP 6480464 butylidenephthalide results in increased expression of CDKN1B protein CTD PMID:16987298 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of CDKN1B mRNA CTD PMID:32387197 1,2-dimethylhydrazine multiple interactions ISO RGD:69116 6480464 Folic Acid inhibits the reaction [1, 2-Dimethylhydrazine results in decreased expression of CDKN1B mRNA] CTD PMID:22206623 1,2-dimethylhydrazine decreases expression ISO RGD:69116 6480464 1, 2-Dimethylhydrazine results in decreased expression of CDKN1B mRNA CTD PMID:22206623 1,3-thiazolidine-2,4-dione increases expression ISO RGD:69115 6480464 2, 4-thiazolidinedione results in increased expression of CDKN1B protein CTD PMID:15916743 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CDKN1B mRNA CTD PMID:20551477 14-Deoxy-11,12-didehydroandrographolide increases expression ISO RGD:69115 6480464 14-deoxy-11, 12-didehydroandrographolide results in increased expression of CDKN1B mRNA CTD PMID:22101062 15-deoxy-Delta(12,14)-prostaglandin J2 decreases expression ISO RGD:69115 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in decreased expression of CDKN1B protein CTD PMID:15729575 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CDKN1B mRNA CTD PMID:17557909 17beta-estradiol increases degradation ISO RGD:69115 6480464 Estradiol results in increased degradation of CDKN1B protein CTD PMID:17283133 17beta-estradiol increases expression ISO RGD:69115 6480464 Estradiol analog results in increased expression of CDKN1B protein CTD PMID:36460128 17beta-estradiol increases phosphorylation ISO RGD:69115 6480464 Estradiol results in increased phosphorylation of CDKN1B protein CTD PMID:23029392 17beta-estradiol decreases expression ISO RGD:69115 6480464 Estradiol results in decreased expression of CDKN1B mRNA CTD PMID:22064387 17beta-estradiol increases expression ISO RGD:69116 6480464 Estradiol results in increased expression of CDKN1B mRNA CTD PMID:17640349 17beta-estradiol affects expression ISO RGD:69116 6480464 Estradiol affects the expression of CDKN1B mRNA CTD PMID:15598610 17beta-estradiol multiple interactions ISO RGD:69115 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] more ... CTD PMID:17283133 more ... 17beta-hydroxy-5alpha-androstan-3-one decreases expression ISO RGD:69115 6480464 Dihydrotestosterone results in decreased expression of CDKN1B mRNA CTD PMID:26804032 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO RGD:69115 6480464 Dihydrotestosterone inhibits the reaction [[Curcumin co-treated with Quercetin] results in increased expression of CDKN1B protein] CTD PMID:27132804 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:69115 6480464 2 more ... CTD PMID:26988655 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69115 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of CDKN1B protein more ... CTD PMID:15157999 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDKN1B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69116 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA, Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein CTD PMID:10398686 more ... 2,3,7,8-tetrachlorodibenzodioxine affects response to substance ISO RGD:69116 6480464 CDKN1B protein affects the susceptibility to Tetrachlorodibenzodioxin CTD PMID:20805476 2,3,7,8-tetrachlorodibenzodioxine affects localization ISO RGD:69116 6480464 Tetrachlorodibenzodioxin affects the localization of CDKN1B protein CTD PMID:20805476 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN1B mRNA, Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein CTD PMID:14742689 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:69115 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein CTD PMID:15157999 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:69116 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] more ... CTD PMID:12883080 more ... 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2-acetamidofluorene multiple interactions EXP 6480464 2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein], Pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]] CTD PMID:17582756 2-amino-2-deoxy-D-glucopyranose decreases expression EXP 6480464 Glucosamine results in decreased expression of CDKN1B protein CTD PMID:15654767 2-cyclopenten-1-one increases expression ISO RGD:69115 6480464 cyclopentenone results in increased expression of CDKN1B CTD PMID:16061222 2-hydroxypropanoic acid increases expression ISO RGD:69115 6480464 Lactic Acid results in increased expression of CDKN1B mRNA CTD PMID:30851411 2-methoxy-17beta-estradiol increases expression ISO RGD:69115 6480464 2-Methoxyestradiol results in increased expression of CDKN1B protein CTD PMID:23967052 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of CDKN1B mRNA CTD PMID:19643169 25-hydroxycholesterol increases expression EXP 6480464 25-hydroxycholesterol results in increased expression of CDKN1B mRNA CTD PMID:17161435 3',5'-cyclic AMP multiple interactions EXP 6480464 [Pentoxifylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein more ... CTD PMID:21693435 3',5'-cyclic AMP multiple interactions ISO RGD:69115 6480464 [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein CTD PMID:21693435 3,3',5-triiodo-L-thyronine decreases expression EXP 6480464 Triiodothyronine results in decreased expression of CDKN1B mRNA, Triiodothyronine results in decreased expression of CDKN1B protein CTD PMID:16021636 3,3',5-triiodo-L-thyronine decreases expression ISO RGD:69116 6480464 Triiodothyronine results in decreased expression of CDKN1B protein CTD PMID:20638743 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:69116 6480464 THRB protein promotes the reaction [Triiodothyronine results in decreased expression of CDKN1B protein] CTD PMID:20638743 3,3',5-triiodo-L-thyronine decreases expression ISO RGD:69115 6480464 Triiodothyronine results in decreased expression of CDKN1B protein CTD PMID:16021636 3,3'-diindolylmethane increases expression ISO RGD:69115 6480464 3, 3'-diindolylmethane results in increased expression of CDKN1B protein CTD PMID:22290291 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69116 6480464 5 more ... CTD PMID:24646949 more ... 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:69115 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA more ... CTD PMID:28628672 3-methylcholanthrene multiple interactions ISO RGD:69115 6480464 Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein], resveratrol inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] CTD PMID:18022818 3-methylcholanthrene increases response to substance ISO RGD:69115 6480464 CDKN1B protein results in increased susceptibility to Methylcholanthrene CTD PMID:18022818 3-methylcholanthrene increases expression ISO RGD:69115 6480464 Methylcholanthrene results in increased expression of CDKN1B protein CTD PMID:18022818 4,4'-sulfonyldiphenol multiple interactions ISO RGD:69115 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases expression ISO RGD:69115 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CDKN1B protein CTD PMID:30292839 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one decreases expression ISO RGD:69115 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein CTD PMID:18805435 , PMID:30236600 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one multiple interactions ISO RGD:69115 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of CDKN1B protein] CTD PMID:18805435 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid affects localization ISO RGD:69115 6480464 Am 580 affects the localization of CDKN1B protein CTD PMID:16618747 4-hydroxyphenyl retinamide increases expression ISO RGD:69115 6480464 Fenretinide results in increased expression of CDKN1B protein CTD PMID:16270382 4-nitroquinoline N-oxide decreases expression ISO RGD:69116 6480464 4-Nitroquinoline-1-oxide results in decreased expression of CDKN1B mRNA CTD PMID:22561872 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of CDKN1B protein CTD PMID:26804764 4-nonylphenol decreases expression ISO RGD:69115 6480464 4-nonylphenol results in decreased expression of CDKN1B mRNA CTD PMID:26804032 4-tert-Octylphenol increases phosphorylation ISO RGD:69115 6480464 4-tert-octylphenol results in increased phosphorylation of CDKN1B protein CTD PMID:32466334 4-vinylcyclohexene dioxide affects expression ISO RGD:69116 6480464 4-vinyl-1-cyclohexene dioxide affects the expression of CDKN1B mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine multiple interactions ISO RGD:69115 6480464 [Decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA, [Decitabine co-treated with trichostatin A] results in increased expression of CDKN1B mRNA CTD PMID:17185465 , PMID:18622747 5-aza-2'-deoxycytidine decreases expression ISO RGD:69116 6480464 Decitabine results in decreased expression of CDKN1B mRNA CTD PMID:27915011 5-aza-2'-deoxycytidine affects expression ISO RGD:69115 6480464 [Decitabine affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA CTD PMID:18544619 5-fluorouracil affects response to substance ISO RGD:69115 6480464 CDKN1B protein affects the susceptibility to Fluorouracil CTD PMID:17217824 5-fluorouracil decreases expression ISO RGD:69115 6480464 Fluorouracil results in decreased expression of CDKN1B mRNA CTD PMID:18930000 5-iodotubercidin decreases phosphorylation EXP 6480464 5-iodotubercidin results in decreased phosphorylation of CDKN1B protein CTD PMID:26953159 6-propyl-2-thiouracil decreases expression ISO RGD:69116 6480464 Propylthiouracil results in decreased expression of CDKN1B protein CTD PMID:29578053 9-cis-retinoic acid increases stability ISO RGD:69115 6480464 Alitretinoin results in increased stability of CDKN1B protein CTD PMID:11348869 9-cis-retinoic acid multiple interactions ISO RGD:69115 6480464 Alitretinoin inhibits the reaction [[[PDGFB protein binds to PDGFB protein] which co-treated with INS protein] results in decreased expression of CDKN1B protein], seocalcitol inhibits the reaction [Alitretinoin results in increased expression of CDKN1B protein] CTD PMID:11348869 , PMID:16340750 9-cis-retinoic acid increases expression ISO RGD:69115 6480464 Alitretinoin results in increased expression of CDKN1B protein CTD PMID:16340750 acetylsalicylic acid multiple interactions ISO RGD:69115 6480464 [troglitazone co-treated with Aspirin] results in increased expression of CDKN1B protein CTD PMID:19908241 acetylsalicylic acid increases expression ISO RGD:69116 6480464 Aspirin results in increased expression of CDKN1B protein CTD PMID:16880202 acrolein multiple interactions EXP 6480464 [ferric oxide analog co-treated with Acrolein] results in decreased expression of CDKN1B protein CTD PMID:24847785 acrylamide decreases expression ISO RGD:69115 6480464 Acrylamide results in decreased expression of CDKN1B protein CTD PMID:20734998 acrylamide multiple interactions ISO RGD:69116 6480464 [Acrylamide co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein CTD PMID:30409764 acrylonitrile decreases expression ISO RGD:69115 6480464 Acrylonitrile results in decreased expression of CDKN1B protein CTD PMID:30236600 acrylonitrile increases expression ISO RGD:69115 6480464 Acrylonitrile results in increased expression of CDKN1B protein CTD PMID:33132245 acteoside multiple interactions ISO RGD:69115 6480464 acteoside promotes the reaction [CDKN1B protein binds to CDK4 protein], acteoside promotes the reaction [CDKN1B protein binds to CDK6 protein] CTD PMID:17634406 acteoside increases expression ISO RGD:69115 6480464 acteoside results in increased expression of CDKN1B mRNA, acteoside results in increased expression of CDKN1B protein CTD PMID:17634406 afimoxifene multiple interactions ISO RGD:69115 6480464 [afimoxifene co-treated with lapatinib] promotes the reaction [CDKN1B protein binds to and results in decreased activity of [CCNE1 protein binds to CDK2 protein]] more ... CTD PMID:15665275 afimoxifene increases expression ISO RGD:69115 6480464 afimoxifene results in increased expression of CDKN1B protein CTD PMID:15665275 afimoxifene increases expression ISO RGD:69116 6480464 afimoxifene results in increased expression of CDKN1B mRNA CTD PMID:17640349 aflatoxin B1 decreases methylation ISO RGD:69115 6480464 Aflatoxin B1 results in decreased methylation of CDKN1B gene CTD PMID:27153756 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CDKN1B mRNA, Aflatoxin B1 results in decreased expression of CDKN1B protein CTD PMID:34015426 aldehydo-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of CDKN1B protein CTD PMID:15654767 aldehydo-D-glucose increases expression EXP 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:22561310 aldehydo-D-glucose increases expression ISO RGD:69115 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:33992720 aldehydo-D-glucose multiple interactions ISO RGD:69115 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA] CTD PMID:33962019 aldehydo-D-glucose multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] more ... CTD PMID:22561310 all-trans-retinoic acid multiple interactions ISO RGD:69115 6480464 [Tretinoin co-treated with IFNG protein] results in increased expression of CDKN1B protein more ... CTD PMID:11348869 more ... all-trans-retinoic acid increases stability ISO RGD:69115 6480464 Tretinoin results in increased stability of CDKN1B protein CTD PMID:11348869 all-trans-retinoic acid affects expression ISO RGD:69115 6480464 Tretinoin affects the expression of CDKN1B mRNA CTD PMID:21924320 all-trans-retinoic acid increases phosphorylation EXP 6480464 Tretinoin results in increased phosphorylation of CDKN1B protein CTD PMID:16618747 all-trans-retinoic acid affects localization EXP 6480464 Tretinoin affects the localization of CDKN1B protein CTD PMID:16618747 all-trans-retinoic acid increases phosphorylation ISO RGD:69115 6480464 Tretinoin results in increased phosphorylation of CDKN1B protein CTD PMID:16618747 all-trans-retinoic acid increases expression ISO RGD:69115 6480464 Tretinoin results in increased expression of CDKN1B more ... CTD PMID:11519864 more ... all-trans-retinoic acid affects localization ISO RGD:69115 6480464 Tretinoin affects the localization of CDKN1B protein CTD PMID:16618747 allose increases expression ISO RGD:69115 6480464 allose results in increased expression of CDKN1B protein CTD PMID:18930000 Allylamine multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Allylamine results in increased expression of CDKN1B protein] CTD PMID:15048878 Allylamine increases expression EXP 6480464 Allylamine results in increased expression of CDKN1B protein CTD PMID:15048878 alpha-naphthoflavone multiple interactions ISO RGD:69115 6480464 alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDKN1B protein], alpha-naphthoflavone inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] CTD PMID:15157999 , PMID:22266097 alvocidib increases cleavage ISO RGD:69115 6480464 alvocidib results in increased cleavage of CDKN1B protein CTD PMID:10537362 alvocidib increases expression ISO RGD:69115 6480464 [alvocidib results in increased expression of TP53 protein] which results in increased expression of CDKN1B protein, alvocidib results in increased expression of CDKN1B protein CTD PMID:12589031 , PMID:15180955 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CDKN1B mRNA CTD PMID:16483693 anilines increases expression ISO RGD:69115 6480464 Aniline Compounds results in increased expression of CDKN1B protein CTD PMID:25123791 anthocyanin increases expression ISO RGD:69115 6480464 Anthocyanins results in increased expression of CDKN1B protein CTD PMID:27444805 aristolochic acid A decreases expression ISO RGD:69115 6480464 aristolochic acid I results in decreased expression of CDKN1B mRNA CTD PMID:33212167 arotinoid acid increases stability ISO RGD:69115 6480464 4-(2-(5 more ... CTD PMID:11348869 arotinoid acid multiple interactions ISO RGD:69115 6480464 4-(2-(5 more ... CTD PMID:11348869 arsane decreases expression ISO RGD:69116 6480464 Arsenic results in decreased expression of CDKN1B mRNA CTD PMID:19654921 arsane affects methylation ISO RGD:69115 6480464 Arsenic affects the methylation of CDKN1B gene CTD PMID:25304211 arsane multiple interactions ISO RGD:69115 6480464 [silybin co-treated with Arsenic] results in increased expression of CDKN1B protein CTD PMID:25868784 arsenic atom decreases expression ISO RGD:69116 6480464 Arsenic results in decreased expression of CDKN1B mRNA CTD PMID:19654921 arsenic atom affects methylation ISO RGD:69115 6480464 Arsenic affects the methylation of CDKN1B gene CTD PMID:25304211 arsenic atom multiple interactions ISO RGD:69115 6480464 [silybin co-treated with Arsenic] results in increased expression of CDKN1B protein CTD PMID:25868784 arsenite(3-) increases methylation ISO RGD:69115 6480464 arsenite results in increased methylation of CDKN1B promoter CTD PMID:23974009 arsenous acid decreases expression ISO RGD:69115 6480464 Arsenic Trioxide results in decreased expression of CDKN1B mRNA CTD PMID:19769630 arsenous acid multiple interactions ISO RGD:69115 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CDKN1B protein more ... CTD PMID:20698225 more ... arsenous acid increases expression ISO RGD:69115 6480464 Arsenic Trioxide results in increased expression of CDKN1B gene more ... CTD PMID:19236751 more ... aspartame multiple interactions ISO RGD:69116 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CDKN1B mRNA CTD PMID:23783067 aspartame decreases expression ISO RGD:69115 6480464 Aspartame results in decreased expression of CDKN1B protein CTD PMID:33992720 atorvastatin calcium multiple interactions ISO RGD:69115 6480464 [Atorvastatin co-treated with Celecoxib] results in increased expression of CDKN1B protein CTD PMID:18172863 atorvastatin calcium increases expression ISO RGD:69115 6480464 Atorvastatin results in increased expression of CDKN1B protein CTD PMID:16470222 atrazine multiple interactions ISO RGD:69115 6480464 [Atrazine co-treated with Arsenates] results in increased expression of CDKN1B mRNA CTD PMID:18585445 benzene decreases expression ISO RGD:69116 6480464 Benzene results in decreased expression of CDKN1B mRNA CTD PMID:20018183 benzo[a]pyrene decreases expression ISO RGD:69116 6480464 Benzo(a)pyrene results in decreased expression of CDKN1B mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:69115 6480464 Benzo(a)pyrene results in decreased expression of CDKN1B protein CTD PMID:30236600 benzo[a]pyrene affects methylation ISO RGD:69115 6480464 Benzo(a)pyrene affects the methylation of CDKN1B promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:69116 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN1B mRNA more ... CTD PMID:21995607 , PMID:25820237 benzo[a]pyrene increases expression ISO RGD:69116 6480464 Benzo(a)pyrene results in increased expression of CDKN1B mRNA CTD PMID:21995607 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CDKN1B protein CTD PMID:17141280 benzo[a]pyrene multiple interactions EXP 6480464 AHR affects the reaction [Benzo(a)pyrene results in decreased expression of CDKN1B protein] CTD PMID:17141280 Benzo[ghi]perylene increases expression ISO RGD:69115 6480464 1 more ... CTD PMID:35182551 Benzo[ghi]perylene multiple interactions ISO RGD:69115 6480464 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [1 more ... CTD PMID:35182551 berberine increases expression ISO RGD:69115 6480464 Berberine results in increased expression of CDKN1B protein CTD PMID:16505103 beta-D-glucosamine decreases expression EXP 6480464 Glucosamine results in decreased expression of CDKN1B protein CTD PMID:15654767 beta-hexachlorocyclohexane increases expression ISO RGD:69116 6480464 beta-hexachlorocyclohexane results in increased expression of CDKN1B mRNA CTD PMID:17640349 bicalutamide increases expression ISO RGD:69115 6480464 bicalutamide results in increased expression of CDKN1B CTD PMID:11845989 bis(2-chloroethyl) sulfide decreases expression ISO RGD:69116 6480464 Mustard Gas results in decreased expression of CDKN1B mRNA CTD PMID:15674843 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CDKN1B mRNA, bisphenol A results in increased expression of CDKN1B protein CTD PMID:20692330 more ... bisphenol A increases phosphorylation ISO RGD:69115 6480464 bisphenol A results in increased phosphorylation of CDKN1B protein CTD PMID:32466334 bisphenol A decreases expression ISO RGD:69116 6480464 bisphenol A results in decreased expression of CDKN1B mRNA CTD PMID:33221593 bisphenol A increases expression ISO RGD:69115 6480464 bisphenol A results in increased expression of CDKN1B protein CTD PMID:29383186 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA, [bisphenol A co-treated with tributyltin] results in increased expression of CDKN1B mRNA CTD PMID:31129395 , PMID:36041667 bisphenol A decreases expression ISO RGD:69115 6480464 bisphenol A results in decreased expression of CDKN1B mRNA CTD PMID:27998958 bisphenol A multiple interactions ISO RGD:69115 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDKN1B gene, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CDKN1B mRNA CTD PMID:28628672 , PMID:31601247 bisphenol A affects expression ISO RGD:69115 6480464 bisphenol A affects the expression of CDKN1B protein CTD PMID:25130739 bisphenol A increases expression ISO RGD:69116 6480464 bisphenol A results in increased expression of CDKN1B mRNA, bisphenol A results in increased expression of CDKN1B protein CTD PMID:24809654 , PMID:26063408 bisphenol F multiple interactions ISO RGD:69115 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CDKN1B mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA CTD PMID:36041667 bortezomib multiple interactions ISO RGD:69115 6480464 [Bortezomib co-treated with Butyrates] results in increased cleavage of CDKN1B protein more ... CTD PMID:15173093 more ... bortezomib increases stability ISO RGD:69115 6480464 Bortezomib results in increased stability of CDKN1B protein CTD PMID:15543232 bortezomib increases expression ISO RGD:69115 6480464 Bortezomib results in increased expression of CDKN1B protein CTD PMID:14749476 more ... bosutinib multiple interactions ISO RGD:69116 6480464 Imatinib Mesylate promotes the reaction [bosutinib results in increased expression of CDKN1B protein] CTD PMID:17129604 bosutinib increases expression ISO RGD:69116 6480464 bosutinib results in increased expression of CDKN1B protein CTD PMID:17129604 BQ 123 multiple interactions ISO RGD:69115 6480464 cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [VEGFC protein results in decreased expression of CDKN1B protein] CTD PMID:24184161 brassinolide decreases expression ISO RGD:69115 6480464 brassinolide results in decreased expression of CDKN1B protein CTD PMID:20833159 Brodifacoum decreases expression EXP 6480464 bromfenacoum results in decreased expression of CDKN1B protein CTD PMID:28903499 bucladesine increases expression EXP 6480464 Bucladesine results in increased expression of CDKN1B protein CTD PMID:16718685 , PMID:21693435 budesonide multiple interactions ISO RGD:69116 6480464 Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] CTD PMID:12117777 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of CDKN1B protein CTD PMID:16730872 cadmium atom multiple interactions ISO RGD:69115 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN1B protein, GJA1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN1B protein] CTD PMID:28176351 cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of CDKN1B protein CTD PMID:27658547 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CDKN1B protein CTD PMID:16730872 cadmium dichloride increases expression ISO RGD:69115 6480464 Cadmium Chloride results in increased expression of CDKN1B mRNA CTD PMID:32512071 , PMID:33129824 cadmium dichloride multiple interactions ISO RGD:69115 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN1B protein, GJA1 protein affects the reaction [[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CDKN1B protein] CTD PMID:28176351 cadmium dichloride decreases expression ISO RGD:69115 6480464 Cadmium Chloride results in decreased expression of CDKN1B protein CTD PMID:27510461 cadmium dichloride multiple interactions ISO RGD:69116 6480464 Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein], Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA] CTD PMID:11516527 , PMID:12135628 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CDKN1B mRNA CTD PMID:18636176 calciol multiple interactions ISO RGD:69115 6480464 Cholecalciferol promotes the reaction [CDKN1B protein binds to CDK2 protein], Cholecalciferol results in increased expression of and results in decreased degradation of CDKN1B protein CTD PMID:12907249 calciol increases expression ISO RGD:69115 6480464 Cholecalciferol results in increased expression of CDKN1B mRNA CTD PMID:12907249 calcitriol multiple interactions ISO RGD:69115 6480464 Calcitriol promotes the reaction [CDKN1B protein binds to CDK4 protein], Calcitriol results in decreased phosphorylation of and results in decreased degradation of and results in increased stability of CDKN1B protein CTD PMID:12954644 , PMID:16322758 calcitriol increases expression ISO RGD:69115 6480464 Calcitriol results in increased expression of CDKN1B more ... CTD PMID:10825140 more ... calcium dichloride multiple interactions EXP 6480464 Calcium Chloride inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] CTD PMID:12189186 Calpeptin decreases expression ISO RGD:69116 6480464 calpeptin results in decreased expression of CDKN1B protein modified form CTD PMID:22432027 capsaicin decreases expression ISO RGD:69115 6480464 Capsaicin results in decreased expression of CDKN1B protein CTD PMID:22226932 capsaicin increases expression ISO RGD:69116 6480464 Capsaicin results in increased expression of CDKN1B CTD PMID:20069556 capsaicin increases expression ISO RGD:69115 6480464 Capsaicin results in increased expression of CDKN1B protein CTD PMID:19855437 captan decreases expression ISO RGD:69116 6480464 Captan results in decreased expression of CDKN1B mRNA CTD PMID:31558096 carbamazepine affects expression ISO RGD:69115 6480464 Carbamazepine affects the expression of CDKN1B mRNA CTD PMID:24752500 carbon nanotube decreases expression ISO RGD:69116 6480464 Nanotubes more ... CTD PMID:25554681 carbonyl cyanide p-trifluoromethoxyphenylhydrazone multiple interactions ISO RGD:69115 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone promotes the reaction [CDKN1B protein binds to CDK4 protein] CTD PMID:19819288 carbonyl cyanide p-trifluoromethoxyphenylhydrazone increases expression ISO RGD:69115 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in increased expression of CDKN1B protein CTD PMID:19819288 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of CDKN1B mRNA CTD PMID:19395590 carnosic acid increases expression ISO RGD:69115 6480464 salvin results in increased expression of CDKN1B protein CTD PMID:23239002 carnosic acid multiple interactions ISO RGD:69115 6480464 salvin promotes the reaction [arsenic trioxide results in increased expression of CDKN1B protein] CTD PMID:23239002 casticin increases expression ISO RGD:69115 6480464 casticin results in increased expression of CDKN1B mRNA CTD PMID:27862857 cefaloridine decreases expression EXP 6480464 Cephaloridine results in decreased expression of CDKN1B mRNA CTD PMID:18500788 celecoxib multiple interactions ISO RGD:69115 6480464 [Atorvastatin co-treated with Celecoxib] results in increased expression of CDKN1B protein more ... CTD PMID:18172863 , PMID:21737646 celecoxib increases expression ISO RGD:69115 6480464 Celecoxib results in increased expression of CDKN1B mRNA, Celecoxib results in increased expression of CDKN1B protein CTD PMID:19428934 , PMID:21737646 chenodeoxycholic acid affects localization ISO RGD:69115 6480464 Chenodeoxycholic Acid affects the localization of CDKN1B protein CTD PMID:20818264 chloropicrin increases expression ISO RGD:69115 6480464 chloropicrin results in increased expression of CDKN1B protein CTD PMID:24548678 choline multiple interactions ISO RGD:69116 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene CTD PMID:20938992 chromium(6+) increases expression EXP 6480464 chromium hexavalent ion results in increased expression of CDKN1B protein CTD PMID:21621607 chromium(6+) multiple interactions ISO RGD:69116 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN1B mRNA CTD PMID:25820237 chromium(6+) multiple interactions ISO RGD:69115 6480464 AKT1 protein affects the reaction [Vanadates inhibits the reaction [chromium hexavalent ion affects the localization of CDKN1B protein]] more ... CTD PMID:19377290 ciglitazone increases expression EXP 6480464 ciglitazone results in increased expression of CDKN1B mRNA CTD PMID:20578043 cisplatin multiple interactions ISO RGD:69115 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of CDKN1B mRNA more ... CTD PMID:19636294 more ... cisplatin affects expression ISO RGD:69115 6480464 Cisplatin affects the expression of CDKN1B protein CTD PMID:32562082 cisplatin decreases expression ISO RGD:69116 6480464 Cisplatin results in decreased expression of CDKN1B mRNA CTD PMID:21151649 cisplatin increases expression ISO RGD:69115 6480464 Cisplatin results in increased expression of CDKN1B mRNA, Cisplatin results in increased expression of CDKN1B protein CTD PMID:21092744 more ... cisplatin decreases response to substance ISO RGD:69115 6480464 CDKN1B results in decreased susceptibility to Cisplatin CTD PMID:21652059 clobenpropit multiple interactions ISO RGD:69115 6480464 [HRH4 protein results in increased susceptibility to clobenpropit] which results in increased expression of CDKN1B protein CTD PMID:22363581 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of CDKN1B mRNA CTD PMID:17602206 clotrimazole increases expression ISO RGD:69115 6480464 Clotrimazole results in increased expression of CDKN1B CTD PMID:20724915 copper atom multiple interactions ISO RGD:69115 6480464 [Chelating Agents binds to Copper] which results in increased expression of CDKN1B mRNA, [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 , PMID:30911355 copper atom multiple interactions ISO RGD:69116 6480464 [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 copper(0) multiple interactions ISO RGD:69115 6480464 [Chelating Agents binds to Copper] which results in increased expression of CDKN1B mRNA, [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 , PMID:30911355 copper(0) multiple interactions ISO RGD:69116 6480464 [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 copper(II) chloride affects expression ISO RGD:69116 6480464 cupric chloride affects the expression of CDKN1B protein CTD PMID:23313662 corticosterone multiple interactions EXP 6480464 Corticosterone promotes the reaction [CDKN1B protein binds to CDK4 protein] CTD PMID:12807724 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of CDKN1B protein CTD PMID:12807724 CU-O LINKAGE decreases expression ISO RGD:69115 6480464 cupric oxide results in decreased expression of CDKN1B mRNA CTD PMID:22077320 , PMID:32285662 cudraflavone B multiple interactions ISO RGD:69115 6480464 resveratrol inhibits the reaction [cudraflavone B results in increased expression of CDKN1B protein], sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1B protein] CTD PMID:23881456 cudraflavone B increases expression ISO RGD:69115 6480464 cudraflavone B results in increased expression of CDKN1B protein CTD PMID:23881456 curcumin increases expression ISO RGD:69115 6480464 Curcumin results in increased expression of CDKN1B mRNA, Curcumin results in increased expression of CDKN1B protein CTD PMID:15713895 more ... curcumin increases expression EXP 6480464 Curcumin results in increased expression of CDKN1B protein CTD PMID:17602960 curcumin multiple interactions EXP 6480464 Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1B protein] CTD PMID:17602960 curcumin multiple interactions ISO RGD:69115 6480464 [arsenic trioxide co-treated with Curcumin] results in increased expression of CDKN1B protein more ... CTD PMID:18226269 more ... curcumin increases expression ISO RGD:69116 6480464 Curcumin results in increased expression of CDKN1B mRNA, Curcumin results in increased expression of CDKN1B protein CTD PMID:21594647 , PMID:25822711 curcumin decreases expression ISO RGD:69115 6480464 Curcumin results in decreased expression of CDKN1B protein CTD PMID:18593936 cyclophosphamide multiple interactions ISO RGD:69115 6480464 [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CDKN1B mRNA CTD PMID:16322899 cyclosporin A increases expression ISO RGD:69115 6480464 Cyclosporine results in increased expression of CDKN1B mRNA CTD PMID:20106945 cyclosporin A decreases expression ISO RGD:69115 6480464 Cyclosporine results in decreased expression of CDKN1B mRNA CTD PMID:25562108 cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CDKN1B mRNA CTD PMID:21865292 cytochalasin B increases expression ISO RGD:69115 6480464 Cytochalasin B results in increased expression of CDKN1B protein CTD PMID:27640744 D-glucose increases expression EXP 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:22561310 D-glucose increases expression ISO RGD:69115 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:33992720 D-glucose multiple interactions ISO RGD:69115 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA] CTD PMID:33962019 D-glucose multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] more ... CTD PMID:22561310 daunorubicin multiple interactions EXP 6480464 fasudil affects the reaction [Daunorubicin affects the expression of CDKN1B mRNA] CTD PMID:20037814 daunorubicin affects expression EXP 6480464 Daunorubicin affects the expression of CDKN1B mRNA CTD PMID:20037814 decabromodiphenyl ether decreases expression ISO RGD:69116 6480464 decabromobiphenyl ether results in decreased expression of CDKN1B protein CTD PMID:28572024 , PMID:29578053 deguelin increases expression ISO RGD:69115 6480464 deguelin results in increased expression of CDKN1B mRNA CTD PMID:33512557 desferrioxamine B multiple interactions ISO RGD:69115 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1B mRNA more ... CTD PMID:33962019 , PMID:35690295 dexamethasone multiple interactions ISO RGD:69116 6480464 5 more ... CTD PMID:24646949 more ... dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of CDKN1B mRNA, Dexamethasone results in decreased expression of CDKN1B protein CTD PMID:34537908 dexamethasone decreases expression ISO RGD:69115 6480464 Dexamethasone results in decreased expression of CDKN1B mRNA, Dexamethasone results in decreased expression of CDKN1B protein CTD PMID:34537908 dexamethasone multiple interactions EXP 6480464 [Polyribonucleotides results in decreased expression of MIR17 mRNA] inhibits the reaction [Dexamethasone results in decreased expression of CDKN1B mRNA] more ... CTD PMID:34537908 dexamethasone multiple interactions ISO RGD:69115 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA more ... CTD PMID:28628672 , PMID:34537908 dexamethasone increases expression ISO RGD:69115 6480464 Dexamethasone results in increased expression of CDKN1B mRNA, Dexamethasone results in increased expression of CDKN1B protein CTD PMID:19428934 diacetylmonoxime increases expression ISO RGD:69116 6480464 diacetylmonoxime results in increased expression of CDKN1B protein CTD PMID:15252113 diallyl trisulfide increases expression ISO RGD:69115 6480464 diallyl trisulfide results in increased expression of CDKN1B protein CTD PMID:14693049 diarsenic trioxide decreases expression ISO RGD:69115 6480464 Arsenic Trioxide results in decreased expression of CDKN1B mRNA CTD PMID:19769630 diarsenic trioxide increases expression ISO RGD:69115 6480464 Arsenic Trioxide results in increased expression of CDKN1B gene more ... CTD PMID:19236751 more ... diarsenic trioxide multiple interactions ISO RGD:69115 6480464 [Arsenic Trioxide co-treated with Curcumin] results in increased expression of CDKN1B protein more ... CTD PMID:20698225 more ... dibenzofuran increases expression EXP 6480464 dibenzofuran analog results in increased expression of CDKN1B mRNA, dibenzofuran analog results in increased expression of CDKN1B protein CTD PMID:20566336 dibenzofuran multiple interactions EXP 6480464 AHR protein promotes the reaction [dibenzofuran analog results in increased expression of CDKN1B mRNA] CTD PMID:20566336 diclofenac affects expression ISO RGD:69115 6480464 Diclofenac affects the expression of CDKN1B mRNA CTD PMID:24752500 diethanolamine decreases expression ISO RGD:69116 6480464 diethanolamine results in decreased expression of CDKN1B mRNA CTD PMID:16014740 diethanolamine decreases expression EXP 6480464 diethanolamine results in decreased expression of CDKN1B mRNA CTD PMID:16014740 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CDKN1B mRNA CTD PMID:17292805 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CDKN1B mRNA CTD PMID:21658437 digitonin decreases expression ISO RGD:69116 6480464 Digitonin results in decreased expression of CDKN1B protein CTD PMID:36030841 digitoxin decreases expression ISO RGD:69115 6480464 Digitoxin analog results in decreased expression of CDKN1B protein, Digitoxin results in decreased expression of CDKN1B protein CTD PMID:22037315 dimethyldithiocarbamate multiple interactions ISO RGD:69115 6480464 [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein CTD PMID:17079469 dioscin increases expression ISO RGD:69115 6480464 dioscin results in increased expression of CDKN1B mRNA, dioscin results in increased expression of CDKN1B protein CTD PMID:33359023 dioxygen increases expression ISO RGD:69115 6480464 Oxygen deficiency results in increased expression of CDKN1B mRNA CTD PMID:17914565 disodium selenite increases expression EXP 6480464 Sodium Selenite results in increased expression of CDKN1B protein CTD PMID:19276161 disulfiram increases expression ISO RGD:69115 6480464 Disulfiram results in increased expression of CDKN1B protein CTD PMID:17079463 disulfiram multiple interactions ISO RGD:69116 6480464 [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 disulfiram multiple interactions ISO RGD:69115 6480464 [Disulfiram binds to Copper] which results in increased expression of CDKN1B protein CTD PMID:24690739 divanadium pentaoxide decreases expression ISO RGD:69115 6480464 vanadium pentoxide results in decreased expression of CDKN1B mRNA CTD PMID:17459161 doxorubicin affects expression ISO RGD:69115 6480464 Doxorubicin affects the expression of CDKN1B mRNA, Doxorubicin affects the expression of CDKN1B protein CTD PMID:16036217 more ... doxorubicin increases expression ISO RGD:69115 6480464 Doxorubicin results in increased expression of CDKN1B protein CTD PMID:17935137 doxorubicin multiple interactions ISO RGD:69115 6480464 [Doxorubicin co-treated with Cyclophosphamide] affects the expression of CDKN1B mRNA, wortmannin promotes the reaction [Doxorubicin results in increased expression of CDKN1B protein] CTD PMID:16322899 , PMID:17935137 doxorubicin decreases response to substance ISO RGD:69115 6480464 CDKN1B results in decreased susceptibility to Doxorubicin CTD PMID:21652059 ellipticine decreases expression ISO RGD:69115 6480464 ellipticine results in decreased expression of CDKN1B protein CTD PMID:21843585 entinostat multiple interactions ISO RGD:69115 6480464 [fludarabine co-treated with entinostat] results in decreased expression of CDKN1B protein CTD PMID:15059916 enzalutamide affects expression ISO RGD:69115 6480464 enzalutamide affects the expression of CDKN1B mRNA CTD PMID:30940724 epoxiconazole decreases expression ISO RGD:69116 6480464 epoxiconazole results in decreased expression of CDKN1B mRNA CTD PMID:35436446 esculetin increases expression ISO RGD:69115 6480464 esculetin results in increased expression of CDKN1B protein CTD PMID:31313495 etoposide increases expression ISO RGD:69115 6480464 Etoposide results in increased expression of CDKN1B protein CTD PMID:17935137 etoposide multiple interactions ISO RGD:69115 6480464 wortmannin promotes the reaction [Etoposide results in increased expression of CDKN1B protein] CTD PMID:17935137 eugenol increases expression ISO RGD:69115 6480464 Eugenol results in increased expression of CDKN1B protein CTD PMID:22686307 farnesol increases response to substance ISO RGD:69115 6480464 CDKN1B protein results in increased susceptibility to Farnesol CTD PMID:17138864 farnesol multiple interactions ISO RGD:69115 6480464 Farnesol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] CTD PMID:17138864 farnesol increases expression ISO RGD:69115 6480464 Farnesol results in increased expression of CDKN1B protein CTD PMID:17138864 fasudil multiple interactions EXP 6480464 fasudil affects the reaction [Daunorubicin affects the expression of CDKN1B mRNA] CTD PMID:20037814 fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA CTD PMID:18253720 fenofibrate multiple interactions ISO RGD:69115 6480464 ESR1 protein inhibits the reaction [Fenofibrate results in decreased expression of CDKN1B protein], Estradiol inhibits the reaction [Fenofibrate results in decreased expression of CDKN1B protein] CTD PMID:29134746 fenofibrate decreases expression ISO RGD:69115 6480464 Fenofibrate results in decreased expression of CDKN1B protein CTD PMID:29134746 fenvalerate multiple interactions ISO RGD:69115 6480464 CDKN1B protein inhibits the reaction [fenvalerate results in increased expression of CDK2 mRNA] CTD PMID:22850687 fenvalerate decreases response to substance ISO RGD:69115 6480464 CDKN1B protein results in decreased susceptibility to fenvalerate CTD PMID:22850687 fenvalerate decreases expression ISO RGD:69115 6480464 fenvalerate results in decreased expression of CDKN1B mRNA, fenvalerate results in decreased expression of CDKN1B protein CTD PMID:22850687 ferric oxide multiple interactions EXP 6480464 [ferric oxide analog co-treated with Acrolein] results in decreased expression of CDKN1B protein CTD PMID:24847785 flavanone increases expression ISO RGD:69115 6480464 flavanone results in increased expression of CDKN1B protein CTD PMID:22056764 fluoxetine increases expression ISO RGD:69116 6480464 Fluoxetine results in increased expression of CDKN1B mRNA CTD PMID:21497159 fluoxetine affects expression ISO RGD:69115 6480464 Fluoxetine affects the expression of CDKN1B mRNA CTD PMID:18371935 fluoxetine multiple interactions ISO RGD:69115 6480464 [Fluoxetine results in decreased activity of CKS1B protein] which results in decreased degradation of CDKN1B protein CTD PMID:18371935 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CDKN1B mRNA CTD PMID:24136188 folic acid affects expression ISO RGD:69115 6480464 Folic Acid affects the expression of CDKN1B mRNA CTD PMID:16361273 folic acid increases expression ISO RGD:69115 6480464 Folic Acid results in increased expression of CDKN1B protein CTD PMID:26056802 folic acid multiple interactions ISO RGD:69115 6480464 AG 1879 inhibits the reaction [Folic Acid results in increased expression of CDKN1B protein] more ... CTD PMID:26056802 folic acid multiple interactions ISO RGD:69116 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene more ... CTD PMID:20938992 , PMID:22206623 folpet decreases expression ISO RGD:69116 6480464 folpet results in decreased expression of CDKN1B mRNA CTD PMID:31558096 formaldehyde decreases expression ISO RGD:69115 6480464 Formaldehyde results in decreased expression of CDKN1B protein CTD PMID:30236600 fulvestrant multiple interactions ISO RGD:69115 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of CDKN1B gene more ... CTD PMID:17283133 more ... fulvestrant increases expression ISO RGD:69115 6480464 fulvestrant results in increased expression of CDKN1B protein CTD PMID:21367843 furan increases expression EXP 6480464 furan results in increased expression of CDKN1B mRNA CTD PMID:22079235 gallic acid increases expression ISO RGD:69115 6480464 Gallic Acid results in increased expression of CDKN1B protein CTD PMID:22245431 gamma-tocopherol decreases expression ISO RGD:69115 6480464 gamma-Tocopherol results in decreased expression of CDKN1B protein CTD PMID:12368234 ganglioside GM1 decreases expression EXP 6480464 G(M1) Ganglioside results in decreased expression of CDKN1B protein CTD PMID:15654767 gefitinib multiple interactions ISO RGD:69115 6480464 gefitinib promotes the reaction [[zoledronic acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein] CTD PMID:16322342 gefitinib increases expression ISO RGD:69115 6480464 gefitinib results in increased expression of CDKN1B protein CTD PMID:16740687 , PMID:17513607 gefitinib decreases expression ISO RGD:69115 6480464 gefitinib results in decreased expression of CDKN1B CTD PMID:14679152 gemcitabine decreases response to substance ISO RGD:69115 6480464 CDKN1B results in decreased susceptibility to Gemcitabine CTD PMID:21652059 genistein increases expression ISO RGD:69115 6480464 Genistein results in increased expression of CDKN1B protein CTD PMID:15829497 genistein decreases expression ISO RGD:69116 6480464 Genistein results in decreased expression of CDKN1B mRNA CTD PMID:31593742 genistein increases expression ISO RGD:69116 6480464 Genistein results in increased expression of CDKN1B mRNA CTD PMID:21048042 geraniol increases expression ISO RGD:69115 6480464 geraniol results in increased expression of CDKN1B protein CTD PMID:17138864 , PMID:21371438 geraniol increases response to substance ISO RGD:69115 6480464 CDKN1B protein results in increased susceptibility to geraniol CTD PMID:17138864 geraniol multiple interactions ISO RGD:69115 6480464 geraniol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] CTD PMID:17138864 gingerol decreases expression ISO RGD:69115 6480464 gingerol results in decreased expression of CDKN1B mRNA CTD PMID:28249781 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CDKN1B mRNA CTD PMID:24136188 glucose multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein] more ... CTD PMID:22561310 glucose increases expression ISO RGD:69115 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:33992720 glucose multiple interactions ISO RGD:69115 6480464 [Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA, Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA] CTD PMID:33962019 glucose increases expression EXP 6480464 Glucose results in increased expression of CDKN1B protein CTD PMID:22561310 glycyrrhetinate multiple interactions ISO RGD:69115 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in decreased expression of CDKN1B protein] CTD PMID:31325423 glycyrrhetinic acid multiple interactions ISO RGD:69115 6480464 18alpha-glycyrrhetinic acid inhibits the reaction [[PDGFB protein co-treated with PDGFB protein] results in decreased expression of CDKN1B protein] CTD PMID:31325423 glyphosate decreases expression EXP 6480464 glyphosate results in decreased expression of CDKN1B protein CTD PMID:27486271 glyphosate increases expression ISO RGD:69115 6480464 glyphosate results in increased expression of CDKN1B mRNA CTD PMID:31295307 gold atom multiple interactions ISO RGD:69115 6480464 [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein CTD PMID:17079469 gold(0) multiple interactions ISO RGD:69115 6480464 [Gold binds to Dimethyldithiocarbamate] which results in increased expression of CDKN1B protein CTD PMID:17079469 guggulsterone increases expression ISO RGD:69115 6480464 pregna-4 more ... CTD PMID:17475222 harmine decreases phosphorylation EXP 6480464 Harmine results in decreased phosphorylation of CDKN1B protein CTD PMID:26953159 hemin decreases degradation ISO RGD:69115 6480464 Hemin results in decreased degradation of CDKN1B protein CTD PMID:17283133 heparin decreases expression ISO RGD:69115 6480464 Heparin analog results in decreased expression of CDKN1B protein CTD PMID:20201787 heparin increases expression ISO RGD:69115 6480464 Heparin analog results in increased expression of CDKN1B protein CTD PMID:18057711 hesperetin increases expression ISO RGD:69115 6480464 hesperetin results in increased expression of CDKN1B CTD PMID:17927510 hesperidin multiple interactions ISO RGD:69115 6480464 BIX 02189 promotes the reaction [Hesperidin results in increased expression of CDKN1B mRNA], BIX 02189 promotes the reaction [Hesperidin results in increased expression of CDKN1B protein] CTD PMID:34984768 hesperidin increases expression ISO RGD:69115 6480464 Hesperidin results in increased expression of CDKN1B mRNA, Hesperidin results in increased expression of CDKN1B protein CTD PMID:34984768 hexachlorobenzene increases expression EXP 6480464 Hexachlorobenzene results in increased expression of CDKN1B protein CTD PMID:25093615 hexachlorobenzene multiple interactions ISO RGD:69115 6480464 Hexachlorobenzene affects the reaction [CDKN1B protein binds to SRC protein], Hexachlorobenzene promotes the reaction [CDKN1B protein binds to CCNE1 protein] CTD PMID:28215542 hexadecanoic acid decreases phosphorylation ISO RGD:69115 6480464 Palmitic Acid results in decreased phosphorylation of CDKN1B protein CTD PMID:28073184 histamine multiple interactions ISO RGD:69115 6480464 [HRH4 protein results in increased susceptibility to Histamine] which results in increased expression of CDKN1B protein CTD PMID:22363581 hydralazine multiple interactions EXP 6480464 [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 hydrochlorothiazide multiple interactions EXP 6480464 [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 hydrogen chloride affects localization ISO RGD:69115 6480464 Hydrochloric Acid affects the localization of CDKN1B protein CTD PMID:20818264 hydroxyurea increases expression ISO RGD:69115 6480464 Hydroxyurea results in increased expression of CDKN1B protein CTD PMID:10961388 hydroxyurea multiple interactions ISO RGD:69115 6480464 [Valproic Acid co-treated with Hydroxyurea] results in increased expression of CDKN1B mRNA CTD PMID:17653085 indirubin increases expression ISO RGD:69116 6480464 indirubin results in increased expression of CDKN1B protein CTD PMID:18344322 indirubin multiple interactions ISO RGD:69116 6480464 indirubin promotes the reaction [tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] more ... CTD PMID:18344322 indole-3-methanol increases expression ISO RGD:69115 6480464 indole-3-carbinol analog results in increased expression of CDKN1B protein, indole-3-carbinol results in increased expression of CDKN1B CTD PMID:16082211 , PMID:20570586 indometacin decreases expression ISO RGD:69115 6480464 Indomethacin results in decreased expression of CDKN1B mRNA CTD PMID:16984733 indometacin multiple interactions ISO RGD:69115 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CDKN1B mRNA more ... CTD PMID:28628672 indometacin increases expression ISO RGD:69115 6480464 Indomethacin results in increased expression of CDKN1B mRNA, Indomethacin results in increased expression of CDKN1B protein CTD PMID:11260862 , PMID:19428934 inulin multiple interactions ISO RGD:69116 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CDKN1B mRNA CTD PMID:36331819 isoeugenol increases expression ISO RGD:69115 6480464 isoeugenol results in increased expression of CDKN1B protein CTD PMID:22686307 isoflavones increases expression ISO RGD:69115 6480464 Isoflavones results in increased expression of CDKN1B protein CTD PMID:17374662 isoliquiritigenin decreases expression ISO RGD:69116 6480464 isoliquiritigenin results in decreased expression of CDKN1B mRNA CTD PMID:27702603 isoprene decreases expression ISO RGD:69115 6480464 isoprene results in decreased expression of CDKN1B protein CTD PMID:30236600 ivermectin increases expression ISO RGD:69115 6480464 Ivermectin results in increased expression of CDKN1B protein CTD PMID:28811376 ivermectin decreases expression ISO RGD:69115 6480464 Ivermectin results in decreased expression of CDKN1B protein CTD PMID:32959892 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CDKN1B mRNA CTD PMID:25808816 kojic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA, [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA CTD PMID:18544905 L-ascorbic acid multiple interactions EXP 6480464 [Ascorbic Acid co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CDKN1B mRNA CTD PMID:18544905 L-cysteine decreases expression ISO RGD:69115 6480464 Cysteine analog results in decreased expression of CDKN1B protein CTD PMID:15890017 L-methionine multiple interactions ISO RGD:69116 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CDKN1B gene CTD PMID:20938992 L-mimosine increases expression ISO RGD:69115 6480464 Mimosine results in increased expression of CDKN1B CTD PMID:10530763 lactacystin increases expression ISO RGD:69115 6480464 lactacystin results in increased expression of CDKN1B protein CTD PMID:12149143 lactacystin multiple interactions ISO RGD:69115 6480464 lactacystin inhibits the reaction [Estradiol results in increased degradation of CDKN1B protein] CTD PMID:17283133 , PMID:23029392 lamivudine multiple interactions ISO RGD:69115 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA CTD PMID:15784690 lapatinib multiple interactions ISO RGD:69115 6480464 [afimoxifene co-treated with Lapatinib] promotes the reaction [CDKN1B protein binds to and results in decreased activity of [CCNE1 protein binds to CDK2 protein]] more ... CTD PMID:15665275 more ... lapatinib increases expression ISO RGD:69115 6480464 lapatinib results in increased expression of CDKN1B protein CTD PMID:15665275 , PMID:20701607 Licochalcone B increases expression ISO RGD:69115 6480464 licochalcone B results in increased expression of CDKN1B protein CTD PMID:35948134 lidocaine affects expression ISO RGD:69116 6480464 Lidocaine affects the expression of CDKN1B mRNA CTD PMID:18931217 linalool increases expression ISO RGD:69115 6480464 linalool results in increased expression of CDKN1B mRNA CTD PMID:19922762 lipopolysaccharide multiple interactions ISO RGD:69116 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Lipopolysaccharides affects the expression of CDKN1B protein] more ... CTD PMID:12883080 lipopolysaccharide increases expression ISO RGD:69116 6480464 Lipopolysaccharides results in increased expression of CDKN1B mRNA, Lipopolysaccharides results in increased expression of CDKN1B protein alternative form CTD PMID:12883080 lipopolysaccharide affects expression ISO RGD:69116 6480464 Lipopolysaccharides affects the expression of CDKN1B protein CTD PMID:12883080 lithium atom decreases expression EXP 6480464 Lithium results in decreased expression of CDKN1B mRNA, Lithium results in decreased expression of CDKN1B protein CTD PMID:15687245 , PMID:18296634 lithium chloride decreases expression ISO RGD:69115 6480464 Lithium Chloride results in decreased expression of CDKN1B mRNA CTD PMID:17440966 lithium hydride decreases expression EXP 6480464 Lithium results in decreased expression of CDKN1B mRNA, Lithium results in decreased expression of CDKN1B protein CTD PMID:15687245 , PMID:18296634 lovastatin increases expression EXP 6480464 Lovastatin results in increased expression of CDKN1B mRNA, Lovastatin results in increased expression of CDKN1B protein CTD PMID:20578043 , PMID:9848777 lovastatin increases expression ISO RGD:69115 6480464 Lovastatin results in increased expression of CDKN1B protein CTD PMID:10502407 more ... luteolin increases expression ISO RGD:69115 6480464 Luteolin results in increased expression of CDKN1B protein CTD PMID:11322924 LY294002 multiple interactions ISO RGD:69115 6480464 [decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of CDKN1B mRNA, [resveratrol co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] results in increased expression of CDKN1B protein CTD PMID:18622747 , PMID:21179458 LY294002 increases expression ISO RGD:69115 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein CTD PMID:11322924 more ... LY294002 increases expression ISO RGD:69116 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of CDKN1B protein CTD PMID:15601625 Maxacalcitol increases expression ISO RGD:69115 6480464 maxacalcitol results in increased expression of CDKN1B protein CTD PMID:16039115 medroxyprogesterone acetate multiple interactions ISO RGD:69115 6480464 Estradiol promotes the reaction [Medroxyprogesterone Acetate results in increased expression of CDKN1B protein], Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein] CTD PMID:17283133 medroxyprogesterone acetate increases expression ISO RGD:69115 6480464 Medroxyprogesterone Acetate results in increased expression of CDKN1B protein CTD PMID:17283133 melatonin multiple interactions ISO RGD:69115 6480464 Melatonin inhibits the reaction [[Glucose co-treated with Deferoxamine] results in increased expression of CDKN1B mRNA] CTD PMID:33962019 menadione multiple interactions ISO RGD:69115 6480464 [sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein, SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein] CTD PMID:19082730 metformin multiple interactions ISO RGD:69115 6480464 [Paclitaxel co-treated with Metformin] results in increased expression of CDKN1B mRNA CTD PMID:29309887 methidathion increases expression ISO RGD:69116 6480464 methidathion results in increased expression of CDKN1B mRNA CTD PMID:34813904 methotrexate affects response to substance ISO RGD:69115 6480464 CDKN1B protein affects the susceptibility to Methotrexate CTD PMID:17217824 methotrexate increases expression ISO RGD:69115 6480464 Methotrexate results in increased expression of CDKN1B mRNA CTD PMID:22183962 methoxsalen multiple interactions ISO RGD:69115 6480464 Methoxsalen inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CDKN1B protein] CTD PMID:15157999 methylseleninic acid multiple interactions ISO RGD:69115 6480464 KLF4 protein affects the reaction [methylselenic acid results in increased expression of CDKN1B mRNA] more ... CTD PMID:17847021 , PMID:18314491 methylseleninic acid affects expression EXP 6480464 methylselenic acid affects the expression of CDKN1B protein CTD PMID:12017302 methylseleninic acid increases expression ISO RGD:69115 6480464 methylselenic acid results in increased expression of CDKN1B mRNA, methylselenic acid results in increased expression of CDKN1B protein CTD PMID:17847021 , PMID:18314491 mifepristone multiple interactions ISO RGD:69115 6480464 Mifepristone inhibits the reaction [[Medroxyprogesterone Acetate co-treated with Estradiol] results in increased expression of CDKN1B protein] more ... CTD PMID:17283133 more ... mifepristone increases expression ISO RGD:69115 6480464 Mifepristone results in increased expression of CDKN1B mRNA, Mifepristone results in increased expression of CDKN1B protein CTD PMID:34537908 minocycline increases expression ISO RGD:69115 6480464 Minocycline results in increased expression of CDKN1B mRNA, Minocycline results in increased expression of CDKN1B protein CTD PMID:21719015 mitomycin C affects response to substance ISO RGD:69115 6480464 CDKN1B protein affects the susceptibility to Mitomycin CTD PMID:17217824 ML-7 increases expression ISO RGD:69116 6480464 ML 7 results in increased expression of CDKN1B protein CTD PMID:15252113 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:69116 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:31884101 monobenzyl phthalate multiple interactions ISO RGD:69116 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:31884101 monoethyl phthalate multiple interactions ISO RGD:69116 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN1B mRNA CTD PMID:31884101 monosodium L-glutamate multiple interactions ISO RGD:69116 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of CDKN1B mRNA CTD PMID:23783067 motexafin gadolinium increases expression ISO RGD:69115 6480464 motexafin gadolinium results in increased expression of CDKN1B mRNA CTD PMID:16357179 motexafin gadolinium multiple interactions ISO RGD:69115 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDKN1B mRNA CTD PMID:16357179 mycophenolic acid multiple interactions ISO RGD:69115 6480464 Mycophenolic Acid inhibits the reaction [IL2 protein results in decreased expression of CDKN1B protein] CTD PMID:12193749 myo-inositol hexakisphosphate decreases expression ISO RGD:69115 6480464 Phytic Acid results in decreased expression of CDKN1B protein CTD PMID:15868430 N-(6-acetamidohexyl)acetamide increases expression ISO RGD:69115 6480464 hexamethylene bisacetamide results in increased expression of CDKN1B mRNA CTD PMID:17349212 N-acetyl-L-cysteine increases expression EXP 6480464 Acetylcysteine results in increased expression of CDKN1B protein CTD PMID:17602960 N-acetyl-L-cysteine multiple interactions ISO RGD:69115 6480464 Acetylcysteine inhibits the reaction [Methylcholanthrene results in increased expression of CDKN1B protein] more ... CTD PMID:18022818 , PMID:30917517 N-acetyl-L-cysteine multiple interactions EXP 6480464 Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1B protein] CTD PMID:17602960 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases degradation ISO RGD:69115 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased degradation of CDKN1B protein CTD PMID:17283133 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO RGD:69116 6480464 Methylnitronitrosoguanidine results in increased expression of CDKN1B protein CTD PMID:11516527 , PMID:12135628 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO RGD:69116 6480464 Cadmium Chloride inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of CDKN1B protein], Cadmium Chloride promotes the reaction [Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA] CTD PMID:11516527 , PMID:12135628 N-methyl-N'-nitro-N-nitrosoguanidine decreases expression ISO RGD:69116 6480464 Methylnitronitrosoguanidine results in decreased expression of CDKN1B mRNA CTD PMID:12135628 N-nitrosodiethylamine multiple interactions EXP 6480464 2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] more ... CTD PMID:17582756 more ... N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CDKN1B protein CTD PMID:17582756 N-nitrosodiethylamine multiple interactions ISO RGD:69116 6480464 CDKN1B protein inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK2 protein], CDKN1B results in decreased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] CTD PMID:17620307 NAD zwitterion multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein], SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] CTD PMID:22561310 NAD(+) multiple interactions EXP 6480464 NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein], SIRT1 protein promotes the reaction [NAD inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] CTD PMID:22561310 naphthalene decreases expression ISO RGD:69116 6480464 naphthalene results in decreased expression of CDKN1B protein CTD PMID:18687389 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CDKN1B mRNA CTD PMID:22546817 nickel dichloride multiple interactions ISO RGD:69115 6480464 HIF1A protein promotes the reaction [nickel chloride results in increased expression of CDKN1B protein] CTD PMID:28552779 nickel dichloride increases expression ISO RGD:69115 6480464 nickel chloride results in increased expression of CDKN1B protein CTD PMID:28552779 nickel subsulfide decreases expression EXP 6480464 nickel subsulfide results in decreased expression of CDKN1B CTD PMID:23447020 nicotinamide increases expression EXP 6480464 Niacinamide results in increased expression of CDKN1B protein CTD PMID:22561310 nicotinamide multiple interactions EXP 6480464 Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] CTD PMID:22561310 nicotine multiple interactions ISO RGD:69115 6480464 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Nicotine results in decreased expression of CDKN1B protein], Nicotine results in increased expression of and results in increased stability of CDKN1B protein CTD PMID:15231866 , PMID:18805435 nicotine decreases expression ISO RGD:69115 6480464 Nicotine results in decreased expression of CDKN1B protein CTD PMID:18805435 nilutamide decreases expression ISO RGD:69116 6480464 nilutamide results in decreased expression of CDKN1B protein CTD PMID:16616092 nimesulide increases expression ISO RGD:69115 6480464 nimesulide results in increased expression of CDKN1B, nimesulide results in increased expression of CDKN1B protein CTD PMID:12717830 , PMID:14567460 nitroglycerin increases expression EXP 6480464 Nitroglycerin results in increased expression of CDKN1B mRNA CTD PMID:12102619 NS-398 multiple interactions ISO RGD:69115 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFC protein results in decreased expression of CDKN1B protein] CTD PMID:24184161 NS-398 increases expression ISO RGD:69115 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased expression of CDKN1B protein CTD PMID:14567460 ochratoxin A decreases expression ISO RGD:69115 6480464 ochratoxin A results in decreased expression of CDKN1B mRNA CTD PMID:30763683 ochratoxin A multiple interactions ISO RGD:69115 6480464 [Citrinin co-treated with ochratoxin A] results in decreased expression of CDKN1B mRNA, [Citrinin co-treated with ochratoxin A] results in increased expression of CDKN1B mRNA CTD PMID:30428381 ochratoxin A increases expression ISO RGD:69115 6480464 ochratoxin A results in increased expression of CDKN1B mRNA CTD PMID:30428381 orlistat increases expression ISO RGD:69115 6480464 orlistat results in increased expression of CDKN1B protein CTD PMID:15138278 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CDKN1B mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:69116 6480464 Oxaliplatin results in increased expression of CDKN1B protein CTD PMID:30031110 oxaliplatin increases expression ISO RGD:69115 6480464 oxaliplatin results in increased expression of CDKN1B protein CTD PMID:15204521 p-tert-Amylphenol increases phosphorylation ISO RGD:69115 6480464 4-tert-octylphenol results in increased phosphorylation of CDKN1B protein CTD PMID:32466334 paclitaxel multiple interactions ISO RGD:69115 6480464 [Paclitaxel co-treated with Metformin] results in increased expression of CDKN1B mRNA CTD PMID:29309887 palbociclib multiple interactions ISO RGD:69115 6480464 palbociclib promotes the reaction [CCND1 protein binds to CDKN1B protein binds to CDK4 protein] CTD PMID:20473330 palbociclib decreases expression ISO RGD:69115 6480464 palbociclib results in decreased expression of CDKN1B protein CTD PMID:17537993 palbociclib increases expression ISO RGD:69115 6480464 palbociclib results in increased expression of CDKN1B mRNA, palbociclib results in increased expression of CDKN1B protein CTD PMID:17537993 , PMID:20473330 Panduratin A increases expression ISO RGD:69115 6480464 panduratin A results in increased expression of CDKN1B mRNA, panduratin A results in increased expression of CDKN1B protein CTD PMID:16497706 panobinostat increases expression ISO RGD:69115 6480464 panobinostat results in increased expression of CDKN1B protein CTD PMID:18445700 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of CDKN1B mRNA CTD PMID:16701773 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CDKN1B mRNA CTD PMID:33387578 Pentoxifylline multiple interactions EXP 6480464 [Pentoxifylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein CTD PMID:21693435 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:69115 6480464 perfluorooctane sulfonic acid results in decreased expression of CDKN1B protein CTD PMID:29063134 , PMID:32700164 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:69116 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of CDKN1B mRNA CTD PMID:36331819 perfluorooctanoic acid decreases expression ISO RGD:69115 6480464 perfluorooctanoic acid results in decreased expression of CDKN1B protein CTD PMID:29502166 perillyl alcohol increases expression ISO RGD:69115 6480464 perillyl alcohol results in increased expression of CDKN1B protein CTD PMID:17138864 perillyl alcohol increases response to substance ISO RGD:69115 6480464 CDKN1B protein results in increased susceptibility to perillyl alcohol CTD PMID:17138864 perillyl alcohol multiple interactions ISO RGD:69115 6480464 perillyl alcohol promotes the reaction [CDKN1B protein binds to and results in decreased activity of CDK2 protein] CTD PMID:17138864 phenethyl caffeate increases expression EXP 6480464 caffeic acid phenethyl ester results in increased expression of CDKN1B protein CTD PMID:15885897 phenethyl caffeate multiple interactions ISO RGD:69115 6480464 caffeic acid phenethyl ester inhibits the reaction [Folic Acid results in increased expression of CDKN1B protein] CTD PMID:26056802 phenobarbital multiple interactions ISO RGD:69116 6480464 CDKN1B protein inhibits the reaction [[Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDK2 protein], CDKN1B results in decreased susceptibility to [Diethylnitrosamine co-treated with Phenobarbital] CTD PMID:17620307 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of CDKN1B CTD PMID:15603588 phorbol 13-acetate 12-myristate decreases expression ISO RGD:69115 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein CTD PMID:12421932 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69116 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [taiwanin C results in increased expression of CDKN1B protein] CTD PMID:26537528 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:69115 6480464 Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]], Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein] CTD PMID:12421932 phosphatidylcholine multiple interactions ISO RGD:69115 6480464 [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CDKN1B protein CTD PMID:21695227 picoxystrobin decreases expression ISO RGD:69115 6480464 picoxystrobin results in decreased expression of CDKN1B mRNA CTD PMID:33512557 pioglitazone increases expression ISO RGD:69115 6480464 pioglitazone results in increased expression of CDKN1B protein CTD PMID:26643070 pioglitazone multiple interactions ISO RGD:69115 6480464 pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased degradation of CDKN1B protein], PRKAA1 protein affects the reaction [pioglitazone results in increased expression of CDKN1B protein] CTD PMID:26643070 pioglitazone multiple interactions EXP 6480464 pioglitazone inhibits the reaction [2-Acetylaminofluorene promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein]], pioglitazone promotes the reaction [Diethylnitrosamine results in decreased expression of CDKN1B protein] CTD PMID:17582756 piroxicam multiple interactions EXP 6480464 Piroxicam inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] CTD PMID:12189186 platycodin D increases expression ISO RGD:69115 6480464 platycodin D results in increased expression of CDKN1B protein CTD PMID:25431082 , PMID:27432230 potassium chromate multiple interactions ISO RGD:69115 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CDKN1B mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:69115 6480464 potassium chromate(VI) results in decreased expression of CDKN1B mRNA CTD PMID:22079256 potassium dichromate increases expression EXP 6480464 Potassium Dichromate results in increased expression of CDKN1B mRNA CTD PMID:26348139 prednisone increases expression ISO RGD:69115 6480464 Prednisone results in increased expression of CDKN1B protein CTD PMID:15034294 progesterone multiple interactions ISO RGD:69115 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CDKN1B mRNA more ... CTD PMID:18850315 more ... progesterone increases expression ISO RGD:69115 6480464 Progesterone results in increased expression of CDKN1B mRNA, Progesterone results in increased expression of CDKN1B protein CTD PMID:18850315 progesterone affects localization ISO RGD:69115 6480464 Progesterone affects the localization of CDKN1B protein CTD PMID:23029392 pterostilbene increases expression ISO RGD:69115 6480464 pterostilbene results in increased expression of CDKN1B protein CTD PMID:23313376 pyrimidines affects splicing ISO RGD:69115 6480464 Pyrimidines affects the splicing of CDKN1B mRNA CTD PMID:25281741 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Allylamine results in increased expression of CDKN1B protein] CTD PMID:15048878 quercetin multiple interactions ISO RGD:69115 6480464 [Cisplatin co-treated with Quercetin] results in increased expression of CDKN1B mRNA more ... CTD PMID:11322924 more ... quercetin increases expression ISO RGD:69115 6480464 Quercetin results in increased expression of CDKN1B protein CTD PMID:11322924 more ... quinazolines affects splicing ISO RGD:69115 6480464 Quinazolines affects the splicing of CDKN1B mRNA CTD PMID:25281741 rac-lactic acid increases expression ISO RGD:69115 6480464 Lactic Acid results in increased expression of CDKN1B mRNA CTD PMID:30851411 raloxifene increases expression ISO RGD:69115 6480464 Raloxifene Hydrochloride results in increased expression of CDKN1B protein CTD PMID:16536755 reserpine multiple interactions EXP 6480464 [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 resveratrol multiple interactions ISO RGD:69115 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of CDKN1B mRNA more ... CTD PMID:17513867 more ... resveratrol decreases expression EXP 6480464 resveratrol results in decreased expression of CDKN1B mRNA CTD PMID:25905778 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein], SIRT1 protein promotes the reaction [resveratrol inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] CTD PMID:22561310 resveratrol increases expression ISO RGD:69116 6480464 resveratrol results in increased expression of CDKN1B protein CTD PMID:21980390 resveratrol increases expression ISO RGD:69115 6480464 resveratrol results in increased expression of CDKN1B mRNA, resveratrol results in increased expression of CDKN1B protein CTD PMID:15829497 more ... rimonabant increases expression ISO RGD:69115 6480464 Rimonabant results in increased expression of CDKN1B protein CTD PMID:16822929 ritonavir increases expression ISO RGD:69115 6480464 Ritonavir results in increased expression of CDKN1B mRNA CTD PMID:19386116 Ro 41-5253 multiple interactions ISO RGD:69115 6480464 Ro 41-5253 inhibits the reaction [Tretinoin promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CDKN1B protein]] CTD PMID:12421932 rubitecan increases expression ISO RGD:69115 6480464 rubitecan results in increased expression of CDKN1B protein CTD PMID:21695227 rubitecan multiple interactions ISO RGD:69115 6480464 [rubitecan co-treated with Phosphatidylcholines] results in increased expression of CDKN1B protein CTD PMID:21695227 S-butyl-DL-homocysteine (S,R)-sulfoximine multiple interactions EXP 6480464 Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of CDKN1B protein], Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of CDKN1B protein] CTD PMID:17602960 SB 203580 multiple interactions ISO RGD:69115 6480464 SB 203580 inhibits the reaction [[sodium arsenite co-treated with Vitamin K 3] results in increased expression of CDKN1B protein] CTD PMID:19082730 Se-methyl-L-selenocysteine increases expression EXP 6480464 selenomethylselenocysteine results in increased expression of CDKN1B protein CTD PMID:11396176 , PMID:19276161 Se-methylselenocysteine increases expression EXP 6480464 selenomethylselenocysteine results in increased expression of CDKN1B protein CTD PMID:11396176 , PMID:19276161 serpentine asbestos decreases expression ISO RGD:69116 6480464 Asbestos, Serpentine results in decreased expression of CDKN1B mRNA CTD PMID:16251409 silibinin multiple interactions ISO RGD:69116 6480464 Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CDKN1B protein] CTD PMID:25559859 silibinin multiple interactions ISO RGD:69115 6480464 [Silybin co-treated with Arsenic] results in increased expression of CDKN1B protein CTD PMID:25868784 silver atom decreases expression ISO RGD:69116 6480464 Silver results in decreased expression of CDKN1B mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:69116 6480464 Silver results in decreased expression of CDKN1B mRNA CTD PMID:27131904 simvastatin multiple interactions ISO RGD:69115 6480464 [Simvastatin results in decreased degradation of CDKN1B protein] which results in decreased activity of CDK2 protein CTD PMID:17928568 simvastatin increases expression EXP 6480464 Simvastatin results in increased expression of CDKN1B mRNA, Simvastatin results in increased expression of CDKN1B protein CTD PMID:12963647 , PMID:18804536 simvastatin increases expression ISO RGD:69115 6480464 Simvastatin results in increased expression of CDKN1B mRNA, Simvastatin results in increased expression of CDKN1B protein CTD PMID:17428261 more ... sirolimus multiple interactions ISO RGD:69115 6480464 [Cisplatin inhibits the reaction [[Sirolimus results in increased phosphorylation of AKT1 protein] which results in increased phosphorylation of FOXO3 protein]] which results in increased expression of CDKN1B protein more ... CTD PMID:12417722 more ... sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of CDKN1B protein CTD PMID:22561310 sirolimus increases expression ISO RGD:69115 6480464 Sirolimus results in increased expression of CDKN1B protein CTD PMID:15070696 more ... sirolimus multiple interactions EXP 6480464 Niacinamide inhibits the reaction [Sirolimus inhibits the reaction [Glucose results in increased expression of CDKN1B protein]] more ... CTD PMID:19105244 , PMID:22561310 sirolimus multiple interactions ISO RGD:69116 6480464 [Sirolimus co-treated with TGFB1 protein] affects the localization of CDKN1B protein more ... CTD PMID:12417722 , PMID:14979923 sirolimus decreases degradation ISO RGD:69115 6480464 Sirolimus results in decreased degradation of CDKN1B protein CTD PMID:12565877 sirtinol multiple interactions ISO RGD:69115 6480464 sirtinol promotes the reaction [cudraflavone B results in increased expression of CDKN1B protein] CTD PMID:23881456 sodium arsenate increases expression EXP 6480464 sodium arsenate results in increased expression of CDKN1B mRNA, sodium arsenate results in increased expression of CDKN1B protein CTD PMID:14713550 sodium arsenite multiple interactions ISO RGD:69115 6480464 [sodium arsenite co-treated with tetrandrine] results in increased expression of CDKN1B protein more ... CTD PMID:19082730 more ... sodium arsenite decreases expression ISO RGD:69115 6480464 sodium arsenite results in decreased expression of CDKN1B protein CTD PMID:32890875 sodium arsenite increases expression ISO RGD:69115 6480464 sodium arsenite results in increased expression of CDKN1B protein CTD PMID:29039521 , PMID:30123091 sodium arsenite decreases expression ISO RGD:69116 6480464 sodium arsenite results in decreased expression of CDKN1B protein CTD PMID:10764629 sodium arsenite multiple interactions ISO RGD:69116 6480464 CDKN1B protein affects the reaction [sodium arsenite results in increased activity of CASP3 protein] more ... CTD PMID:20566634 sodium arsenite affects expression ISO RGD:69115 6480464 sodium arsenite affects the expression of CDKN1B mRNA CTD PMID:24535192 sorafenib multiple interactions ISO RGD:69115 6480464 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3 more ... CTD PMID:23036488 sorafenib decreases expression EXP 6480464 sorafenib results in decreased expression of CDKN1B protein CTD PMID:21693435 sorafenib multiple interactions EXP 6480464 sorafenib inhibits the reaction [[Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein] CTD PMID:21693435 sorafenib increases expression ISO RGD:69116 6480464 sorafenib results in increased expression of CDKN1B protein CTD PMID:19139124 sorafenib increases expression ISO RGD:69115 6480464 sorafenib results in increased expression of CDKN1B protein CTD PMID:19878585 , PMID:23036488 staurosporine multiple interactions ISO RGD:69115 6480464 Staurosporine inhibits the reaction [Tretinoin results in increased phosphorylation of CDKN1B protein] CTD PMID:16618747 sterigmatocystin decreases expression EXP 6480464 Sterigmatocystin results in decreased expression of CDKN1B mRNA CTD PMID:34126181 stilbenoid increases expression ISO RGD:69115 6480464 Stilbenes analog results in increased expression of CDKN1B mRNA, Stilbenes analog results in increased expression of CDKN1B protein CTD PMID:25980588 sulindac multiple interactions EXP 6480464 Sulindac inhibits the reaction [Azoxymethane results in decreased expression of CDKN1B protein] CTD PMID:12189186 sulindac sulfone increases expression ISO RGD:69115 6480464 sulindac sulfone results in increased expression of CDKN1B mRNA, sulindac sulfone results in increased expression of CDKN1B protein CTD PMID:18593937 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of CDKN1B mRNA CTD PMID:21865292 taiwanin C increases expression ISO RGD:69116 6480464 taiwanin C results in increased expression of CDKN1B protein CTD PMID:26537528 taiwanin C multiple interactions ISO RGD:69116 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [taiwanin C results in increased expression of CDKN1B protein] CTD PMID:26537528 tamoxifen multiple interactions ISO RGD:69115 6480464 [Tamoxifen co-treated with FTI 277] promotes the reaction [CDKN1B protein binds to [CCNE1 protein binds to CDK2 protein]], [Tamoxifen co-treated with tipifarnib] results in increased expression of CDKN1B protein CTD PMID:12866041 , PMID:17876043 tamoxifen increases activity ISO RGD:69115 6480464 Tamoxifen results in increased activity of CDKN1B protein CTD PMID:15665275 Tanshinone I multiple interactions ISO RGD:69116 6480464 indirubin promotes the reaction [tanshinone promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CDKN1B protein]] more ... CTD PMID:18344322 Tanshinone I increases expression ISO RGD:69116 6480464 tanshinone results in increased expression of CDKN1B protein CTD PMID:18344322 temozolomide multiple interactions ISO RGD:69115 6480464 [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein CTD PMID:20980775 temozolomide multiple interactions ISO RGD:69116 6480464 [temozolomide co-treated with O(6)-benzylguanine] results in decreased expression of CDKN1B protein CTD PMID:20980775 terazosin increases expression ISO RGD:69115 6480464 Terazosin results in increased expression of CDKN1B protein CTD PMID:12883741 Terfenadine increases expression ISO RGD:69115 6480464 Terfenadine results in increased expression of CDKN1B protein CTD PMID:12244568 tert-butyl hydroperoxide multiple interactions ISO RGD:69115 6480464 [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1B mRNA CTD PMID:35690295 testosterone decreases expression ISO RGD:69116 6480464 Testosterone results in decreased expression of CDKN1B mRNA CTD PMID:15788153 tetrachloromethane decreases expression ISO RGD:69116 6480464 Carbon Tetrachloride results in decreased expression of CDKN1B protein CTD PMID:12759355 tetrachloromethane multiple interactions ISO RGD:69116 6480464 CDKN1B protein affects the reaction [Carbon Tetrachloride results in increased expression of CDKN1A protein] CTD PMID:12759355 theophylline multiple interactions ISO RGD:69115 6480464 [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein CTD PMID:21693435 theophylline multiple interactions EXP 6480464 [Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein, sorafenib inhibits the reaction [[Theophylline results in increased abundance of Cyclic AMP] which results in increased expression of CDKN1B protein] CTD PMID:21693435 thioacetamide affects localization EXP 6480464 Thioacetamide affects the localization of CDKN1B protein CTD PMID:22659510 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CDKN1B mRNA CTD PMID:34492290 thiophenes multiple interactions ISO RGD:69115 6480464 Thiophenes analog promotes the reaction [Tretinoin results in increased expression of CDKN1B protein] CTD PMID:16140954 tipifarnib multiple interactions ISO RGD:69115 6480464 [Tamoxifen co-treated with tipifarnib] results in increased expression of CDKN1B protein CTD PMID:17876043 tolbutamide increases expression EXP 6480464 Tolbutamide results in increased expression of CDKN1B protein CTD PMID:16718685 toluene 2,4-diisocyanate decreases expression ISO RGD:69116 6480464 Toluene 2, 4-Diisocyanate results in decreased expression of CDKN1B mRNA CTD PMID:21404309 Tomentosin multiple interactions ISO RGD:69115 6480464 Acetylcysteine inhibits the reaction [tomentosin results in increased expression of CDKN1B protein], FOXO3 protein affects the reaction [tomentosin results in increased expression of CDKN1B protein] CTD PMID:30917517 Tomentosin increases expression ISO RGD:69115 6480464 tomentosin results in increased expression of CDKN1B protein CTD PMID:30917517 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CDKN1B mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of CDKN1B mRNA CTD PMID:25729387 trans-isoeugenol increases expression ISO RGD:69115 6480464 isoeugenol results in increased expression of CDKN1B protein CTD PMID:22686307 tributylstannane multiple interactions EXP 6480464 [bisphenol A co-treated with tributyltin] results in increased expression of CDKN1B mRNA CTD PMID:31129395 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CDKN1B mRNA CTD PMID:17553608 trichostatin A multiple interactions ISO RGD:69115 6480464 [decitabine co-treated with trichostatin A] results in increased expression of CDKN1B mRNA more ... CTD PMID:17185465 , PMID:17431121 trichostatin A increases expression ISO RGD:69115 6480464 trichostatin A results in increased expression of CDKN1B mRNA, trichostatin A results in increased expression of CDKN1B protein CTD PMID:17431121 , PMID:23770000 trichostatin A affects expression ISO RGD:69115 6480464 [trichostatin A affects the expression of DNMT3B protein] which affects the expression of CDKN1B mRNA CTD PMID:18544619 Triptolide increases expression EXP 6480464 triptolide results in increased expression of CDKN1B protein CTD PMID:32519852 troglitazone multiple interactions ISO RGD:69115 6480464 [troglitazone binds to and results in increased activity of PPARG protein] which results in decreased degradation of CDKN1B protein more ... CTD PMID:11034103 more ... troglitazone increases expression ISO RGD:69115 6480464 troglitazone results in increased expression of CDKN1B mRNA, troglitazone results in increased expression of CDKN1B protein CTD PMID:11343236 more ... troglitazone affects response to substance ISO RGD:69115 6480464 CDKN1B protein affects the susceptibility to troglitazone CTD PMID:11034103 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of CDKN1B protein CTD PMID:11318962 troglitazone multiple interactions EXP 6480464 [troglitazone co-treated with [Hydrochlorothiazide co-treated with Hydralazine co-treated with Reserpine]] results in decreased expression of CDKN1B protein CTD PMID:11318962 troglitazone decreases expression ISO RGD:69115 6480464 troglitazone results in decreased expression of CDKN1B mRNA, troglitazone results in decreased expression of CDKN1B protein CTD PMID:12680223 urethane decreases expression ISO RGD:69116 6480464 Urethane results in decreased expression of CDKN1B mRNA CTD PMID:12117781 ursolic acid increases expression ISO RGD:69115 6480464 ursolic acid results in increased expression of CDKN1B protein CTD PMID:24802810 valproic acid multiple interactions ISO RGD:69115 6480464 [Valproic Acid co-treated with Hydroxyurea] results in increased expression of CDKN1B mRNA more ... CTD PMID:17653085 , PMID:21737646 valproic acid affects expression ISO RGD:69115 6480464 Valproic Acid affects the expression of CDKN1B mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:69115 6480464 Valproic Acid results in decreased expression of CDKN1B mRNA CTD PMID:23179753 , PMID:28001369 valproic acid increases expression ISO RGD:69116 6480464 Valproic Acid results in increased expression of CDKN1B protein CTD PMID:21708246 valproic acid increases expression ISO RGD:69115 6480464 Valproic Acid results in increased expression of CDKN1B protein CTD PMID:21737646 valsartan multiple interactions ISO RGD:69115 6480464 Valsartan inhibits the reaction [AGT protein results in decreased expression of CDKN1B mRNA] CTD PMID:19225232 vemurafenib multiple interactions ISO RGD:69115 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in increased expression of CDKN1B protein CTD PMID:27169980 vinyl carbamate multiple interactions ISO RGD:69116 6480464 Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] CTD PMID:12117777 vinyl carbamate decreases expression ISO RGD:69116 6480464 vinyl carbamate results in decreased expression of CDKN1B protein CTD PMID:12117777 vitamin E increases expression ISO RGD:69115 6480464 Vitamin E results in increased expression of CDKN1B protein CTD PMID:12352461 vorinostat multiple interactions ISO RGD:69115 6480464 [Bortezomib co-treated with Vorinostat] results in increased cleavage of CDKN1B protein more ... CTD PMID:12446442 more ... vorinostat increases expression ISO RGD:69115 6480464 vorinostat results in increased expression of CDKN1B mRNA, vorinostat results in increased expression of CDKN1B protein CTD PMID:12446442 more ... wogonin increases expression ISO RGD:69115 6480464 wogonin results in increased expression of CDKN1B protein CTD PMID:23872260 wogonin increases expression EXP 6480464 wogonin results in increased expression of CDKN1B protein CTD PMID:23872260 wortmannin multiple interactions ISO RGD:69115 6480464 wortmannin promotes the reaction [Doxorubicin results in increased expression of CDKN1B protein], wortmannin promotes the reaction [Etoposide results in increased expression of CDKN1B protein] CTD PMID:17935137 wortmannin increases expression ISO RGD:69116 6480464 wortmannin results in increased expression of CDKN1B protein CTD PMID:17129604 wortmannin multiple interactions ISO RGD:69116 6480464 Imatinib Mesylate promotes the reaction [wortmannin results in increased expression of CDKN1B protein] CTD PMID:17129604 Y-27632 increases expression EXP 6480464 Y 27632 results in increased expression of CDKN1B mRNA CTD PMID:20578043 zidovudine multiple interactions ISO RGD:69115 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN1B mRNA CTD PMID:15784690 zinc acetate multiple interactions ISO RGD:69115 6480464 [Zinc Acetate co-treated with motexafin gadolinium] results in increased expression of CDKN1B mRNA CTD PMID:16357179 zinc acetate increases expression ISO RGD:69115 6480464 Zinc Acetate results in increased expression of CDKN1B mRNA CTD PMID:16357179 zinc dichloride decreases expression ISO RGD:69115 6480464 zinc chloride results in decreased expression of CDKN1B mRNA CTD PMID:21540303 zoledronic acid multiple interactions ISO RGD:69115 6480464 [Zoledronic Acid co-treated with 4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide] results in decreased expression of CDKN1B protein more ... CTD PMID:16322342 , PMID:19530242
